L
Lifesprout
Developing products for aesthetic and regenerative medicine
About Lifesprout
LifeSprout, founded in September 2015 by leading scientists and surgeons at Johns Hopkins University, specializes in developing next-generation soft tissue restoration products for the aesthetic and reconstructive markets. The company focuses on creating revolutionary solutions for soft tissue replacement and regeneration, utilizing recent breakthroughs in materials science. LifeSprout's products are designed to look and behave like natural tissues, offering minimal downtime and superior results for patients suffering from soft tissue losses due to aging, cancer, and metabolic diseases. The company's business model revolves around research and development, targeting both aesthetic and medical clients, including individuals seeking cosmetic enhancements and patients requiring reconstructive procedures. LifeSprout generates revenue through the sale of its innovative products to healthcare providers and clinics. The company operates in the highly specialized market of regenerative medicine and aesthetic treatments, aiming to provide best-in-class solutions that enhance form and function.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Baltimore, United States
- Employees
- 21
- Open positions
- 6
- Dealroom signal
- 85.1/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Apr 2020 | $29M | $114M | Nexus Capital Management · Redmile Group · Emerald Development Managers | ↗ |
| EARLY VC✓Equity / VC | Jun 2018 | $6.5M | $26M | angelMD · Medytox Investments · TEDCO · Triskelion | — |
Growth signals
Latest recorded traffic for Lifesprout is 2K monthly website visits, up 81.8% over the last three months. Lifesprout's team grew 31.3% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Maryland Stem Cell Research Fund
Abell Foundation
TEDCO
Series A6 investors entered at this stage
angelMD
Medytox Investments
Triskelion
Redmile Group
Nexus Capital Management
Emerald Development Managers
Other known investors4 additional known investors
Johns Hopkins University
Catalio Capital Management
Johns Hopkins Technology Ventures
Medytox Venture Investment
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Lifesprout on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Lifesprout’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.